Figure 1.
RECQL4 shows bimodal distribution, and its expression is significantly associated with clinical outcomes. (A): The frequency distribution calculated by the kernel function for RECQL4 in each molecular subtype and in the overall population is presented. (B): The Kaplan-Meier estimates for distant event-free survival are shown according to the tertiles of RECQL4 expression in ER-positive/HER2-negative tumors.